INTERPACE BIOSCIENCES, INC. Deferred Tax Assets, Capital Loss Carryforwards
INTERPACE BIOSCIENCES, INC. (IDXGD) had Deferred Tax Assets, Capital Loss Carryforwards of $350.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-30
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $350.00K.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $268.00K.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $158.00K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2024-12-31 | $350.00K 10-K · filed 2026-03-30 |
| 2023-12-31 | $268.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $158.00K 10-K · filed 2024-04-01 |